Literature DB >> 29545882

Pterostilbene attenuates acute kidney injury in septic mice.

Yizi Xia1, Ying Chen1, Luming Tang1, Zheng Wang1, Yu Zheng2.   

Abstract

Acute kidney injury (AKI) is a severe complication of sepsis with a high mortality and morbidity. Pterostilbene (Pte) has been suggested to confer anti-apoptotic and anti-inflammatory effects. In the current study, the effects of Pte on AKI were evaluated in septic mice. Cecal ligation and puncture surgery was performed to induce sepsis. The results suggested that Pte administration significantly decreased the levels of serum urea nitrogen and creatinine, and improved the survival rate of septic mice. Additionally, the renal injury induced by sepsis was attenuated by pterostilbene treatment. Notably, pterostilbene reduced Bcl-2-associated X protein expression, and levels of interleukin-1β and tumor necrosis factor-α, and upregulated B-cell lymphoma 2 expression. The results indicate that pterostilbene may serve as a potential therapeutic candidate for the treatment of AKI induced by sepsis.

Entities:  

Keywords:  acute kidney injury; apoptosis; pterostilbene; sepsis

Year:  2018        PMID: 29545882      PMCID: PMC5841077          DOI: 10.3892/etm.2018.5808

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  22 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Cytochrome C release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases.

Authors:  Ronald Jemmerson; Janet M Dubinsky; Nickolay Brustovetsky
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

Review 3.  Recent knowledge on the pathophysiology of septic acute kidney injury: A narrative review.

Authors:  Hoi-Ping Shum; Wing-Wa Yan; Tak Mao Chan
Journal:  J Crit Care       Date:  2015-09-25       Impact factor: 3.425

4.  Sepsis-The Final Common Pathway to Death From Multiple Organ Failure in Infection.

Authors:  Niranjan Kissoon; Ron Daniels; Tom van der Poll; Simon Finfer; Konrad Reinhart
Journal:  Crit Care Med       Date:  2016-06       Impact factor: 7.598

Review 5.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

6.  Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury.

Authors:  Joseph H Holthoff; Zhen Wang; Kathryn A Seely; Neriman Gokden; Philip R Mayeux
Journal:  Kidney Int       Date:  2011-10-05       Impact factor: 10.612

Review 7.  Sepsis-induced acute kidney injury.

Authors:  Hernando Gómez; John A Kellum
Journal:  Curr Opin Crit Care       Date:  2016-12       Impact factor: 3.687

8.  Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages.

Authors:  Liang Chen; Sixing Yang; Elizabeth E Zumbrun; Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2015-03-18       Impact factor: 5.914

Review 9.  Activated protein C in sepsis: the promise of nonanticoagulant activated protein C.

Authors:  Hartmut Weiler; Wolfram Ruf
Journal:  Curr Opin Hematol       Date:  2008-09       Impact factor: 3.284

10.  Early acute kidney injury and sepsis: a multicentre evaluation.

Authors:  Sean M Bagshaw; Carol George; Rinaldo Bellomo
Journal:  Crit Care       Date:  2008-04-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.